Department of Medical Sociology and Health Economics, University Medical Centre Hamburg-Eppendorf, Germany.
Int J Eat Disord. 2012 May;45(4):476-91. doi: 10.1002/eat.20977. Epub 2012 Feb 1.
To review cost-of-illness studies (COIs) and cost-effectiveness analyses (CEAs) of eating disorders (EDs) and to describe their methodological quality.
A systematic literature search was done. Search results passed through a selection process, included studies were classified as COIs, CEAs, or "other cost studies" (OCS). Costs were inflated and converted to 2008 US$ purchasing power parities (PPP). Quality criteria were developed and applied to each study.
Five COI, two CEA, and eleven "OCS" were reviewed. Most studies focused on anorexia nervosa and bulimia nervosa. Annual costs per patient ranged from 1,288 to 8,042 US$-PPP. All interventions, investigated in CEA, were more effective and less costly than the alternative treatments.
The number of publications investigating costs in EDs has increased recently. However, no COI provided a comprehensive estimate of costs, and the comparability of CEA was limited. Nonetheless, the results indicate that the costs arising from EDs are substantial.
回顾关于饮食失调(EDs)的疾病经济负担研究(COIs)和成本效益分析(CEAs),并描述其方法学质量。
进行了系统的文献检索。检索结果经过筛选过程,被纳入的研究被分类为 COIs、CEAs 或“其他成本研究”(OCS)。成本进行了通胀调整,并转换为 2008 年的美国按购买力平价(PPP)计算的美元。为每个研究制定了质量标准并加以应用。
共回顾了 5 项 COI、2 项 CEA 和 11 项“OCS”。大多数研究集中在神经性厌食症和神经性贪食症上。每位患者的年度费用从 1288 美元到 8042 美元不等。CEA 研究中调查的所有干预措施都比替代治疗更有效且成本更低。
最近,研究 ED 成本的出版物数量有所增加。然而,没有 COI 提供了成本的全面估计,并且 CEA 的可比性受到限制。尽管如此,结果表明 ED 产生的成本相当可观。